Clinical Trial Update: Role of Pentoxifylline and Celecoxib in Parkinsonism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the combination of pentoxifylline and celecoxib for Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Celecoxib (Celecoxib)
• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Mostafa Bahaa | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED